Year: 2025

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

Written by Customer Service on October 29, 2025. Posted in Public Companies.

SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its third quarter 2025 financial results and provide a corporate update on the cytisinicline development program on Thursday, November 6, 2025, at 8:30 AM EST. To access the webcast, please use the following link: 3Q25 Earnings Webcast. Alternatively, you may access the live conference call by dialing 888-396-8049 (U.S. & Canada) or 416-764-8646 (International) and referencing conference ID 13756406. A webcast replay will be available approximately three hours after the call and archived on the website...

Blackboxstocks, Inc (NASDAQ: BLBX) Merger Target, REalloys Secures $200 Million Letter of Interest from U.S. EXIM Bank to Advance North America’s First Fully Integrated Mine-to-Magnet Supply Chain

Written by Customer Service on October 29, 2025. Posted in Mergers And Acquisitions.

$200 million Letter of Interest represents EXIM preliminary indication of support under the China and Transformational Exports Program (CTEP), underscoring U.S. commitment to allied Critical-Minerals supply chain independence. DALLAS, Oct. 29, 2025 (GLOBE NEWSWIRE) — Blackboxstocks Inc (NASDAQ: BLBX) Merger Target, REalloys Inc. (“REalloys” or the “Company”), a U.S. company advancing a vertically integrated North American mine-to-magnet rare-earth supply chain, today announced it has secured a $200 million Letter of Interest (“LOI”) from the Export-Import Bank of the United States (EXIM Bank). The Company’s LOI with EXIM represents an indication of potential support from EXIM for a critical-minerals project that supports EXIM’s China Transformational Exports Program (CTEP) mandate, signaling strong U.S. government support for REalloys’...

HeartCore Clarifies Form of One-Time Payment to Stockholders

Written by Customer Service on October 29, 2025. Posted in Dividend Reports And Estimates.

NEW YORK and TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, previously issued a press release announcing that it had authorized a one-time payment to its stockholders in the amount of $0.13 per share of common stock. For U.S. federal tax purposes, this payment to stockholders will be deemed to be a distribution. The Company’s press release incorrectly stated that the one-time payment would be in the form of a dividend, as opposed to a distribution. The record date for holders of the common stock to participate in the distribution is November 10, 2025, and the payment date will be November 17, 2025. The one-time distribution payment of $0.13 per share represents approximately 16.8% of...

Verizon helps families stay connected as Hurricane Melissa makes landfall in Jamaica

Written by Customer Service on October 29, 2025. Posted in Public Companies.

Free calling/texting/data for customers in Jamaica, Turks and Caicos, and the Bahamas and free calling from the US to these countries until Nov 12 What you need to know:In response to Hurricane Melissa, Verizon is offering free wireless and landline calling to Jamaica, Turks and Caicos, and the Bahamas to help our customers connect with loved ones. Customers within Jamaica, Turks and Caicos, and the Bahamas will also receive waived calling, texting and data charges This applies to all consumer and small business customers, including prepaid brands. The offer is effective from October 28 through November 12, 2025.NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Following Hurricane Melissa’s catastrophic Category 5 landfall today in Jamaica, Verizon is helping its customers keep in touch with family and loved ones. From October 28...

SEALSQ Strengthens Strategic Position in RegTech; Following the Recent 28.3% Equity Stake Acquisition, Wecan’s Founder Vincent Pignon Resumes CEO Role

Written by Customer Service on October 29, 2025. Posted in Public Companies.

Geneva, Switzerland, Oct. 29, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (Nasdaq: LAES), (“SEALSQ” or “Company”), a global leader in cybersecurity, semiconductor technology and post-quantum security solutions, today announce that, following the June 2025 strategic acquisition of a 28.3% equity stake in Wecan, the Swiss pioneer in digital compliance platforms for regulated institutions, Wecan’s founder, Vincent Pignon, has resumed his role as Chief Executive Officer to lead the next phase of innovation and growth. Mr. Pignon is a visionary leader with a deep passion for technological innovation. His forward-looking approach and academic rigor have positioned him as a driving force in advancing the adoption of secure, decentralized technologies and shaping the future of this transformative industry. RegTech (Regulatory...

PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer

Written by Customer Service on October 29, 2025. Posted in Public Companies.

Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to be the most dominant type of head and neck cancer in the US by mid 2030s Proposed Amendment to Ongoing VERSATILE-003 Trial to include PFS Endpoint Based Upon Final VERSATILE-002 Trial Data Showing Robust Median Progression Free Survival of 6.3 months and Increased Median Overall Survival of 39.3 months PRINCETON, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that after recent review of the final VERSATILE-002 data, the Company has requested a meeting with the Food and Drug Administration (“FDA”) to explore an...

Argo Drives 5.5x Increase in Connections to GO Station

Written by Customer Service on October 29, 2025. Posted in Public Companies.

Growth in connections to Bradford GO Station demonstrates the power of Argo’s Smart Routing™ system in complementing existing public transit networks and driving increased ridership TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Argo Corporation (TSXV:ARGH) (OTCQX:ARGHF) (“Argo” or the “Company”), a leader in next-generation transit solutions, today announced a 5.5x increase in monthly transfers between Bradford West Gwillimbury (“BWG”) Transit and GO Transit at Bradford GO Station. In September 2025, transfers to and from GO were 5.5x higher versus the 12-month baseline preceding the April launch of Argo’s Smart Routing™ system.This growth demonstrates how Argo’s Smart Routing™ can increase overall transit ridership while feeding more riders into existing fixed transit lines. It follows Argo’s prior announcement...

Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin

Written by Customer Service on October 29, 2025. Posted in Public Companies.

HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, today announced that the Australian Patent Office (IP Australia) has granted Patent No. 2024203598 titled, “PREPARATION OF PRELIPOSOMAL ANNAMYCIN LYOPHILIZATE,” with claims covering certain preliposomal Annamycin lyophilizates with improved stability and high purity, with a base patent term currently extending until June 2040, subject to extension to account for time required to fulfill requirements for regulatory approval. This patent further expands the Company’s intellectual property portfolio globally. Walter Klemp, Chairman and CEO of Moleculin, commented, “As we continue our mission...

Osisko Development Closes C$82.5 Million Private Placement

Written by Customer Service on October 29, 2025. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Oct. 29, 2025 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce the successful closing of its previously-announced oversubscribed private placement offering of 15,409,798 common shares of the Company (the “Common Shares“) for aggregate gross proceeds of approximately C$82.5 million (the “Offering“). The Offering is comprised of the following issuances, on a private placement basis:LIFE Offering: issuances made pursuant to the “listed issuer financing exemption” available under Part 5A of National Instrument 45-106 – Prospectus Exemptions (“NI 45-106“), as amended by Coordinated...

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Written by Customer Service on October 29, 2025. Posted in Public Companies.

COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% of the shares and voting rights in Bavarian Nordic A/S as of October 23, 2025. About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com. Contact investors:Europe: Disa Tuominen, IR Manager, detu@bavarian-nordic.comUS: Graham Morrell, Gilmartin Group, graham@gilmartinir.com, Tel: +1 781 686 9600 Contact media:Nicole Seroff, Vice...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals